Jill Marie Broadfoot - 13 Jan 2022 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
Chief Financial Officer
Signature
Nancy E. Denyes, attorney-in-fact
Issuer symbol
ATYR
Transactions as of
13 Jan 2022
Net transactions value
+$12,980
Form type
4
Filing time
18 Jan 2022, 07:39:32 UTC
Previous filing
23 Nov 2021
Next filing
07 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common stock Purchase $12,980 +1,923 +19% $6.75 12,112 13 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan on November 15, 2021.